About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [344 citations: 1–100 of 337 articles]

Articles published in International Journal of Breast Cancer have been cited 344 times. The following is a list of the 337 articles that have cited the articles published in International Journal of Breast Cancer.

  • Robert Schmadeka, and Bryan E. Harmon, “Triple-Negative Breast Carcinoma Current and Emerging Concepts,” American Journal of Clinical Pathology, vol. 141, no. 4, pp. 462–477, 2014. View at Publisher · View at Google Scholar
  • Yadong Yang, Wenyuan Zhang, Ying Li, Guojian Fang, and Keji Zhang, “Scalded Skin of Rat Treated by Using Fibrin Glue Combined with Allogeneic Bone Marrow Mesenchymal Stem Cells,” Annals of Dermatology, vol. 26, no. 3, pp. 289, 2014. View at Publisher · View at Google Scholar
  • Robin M. Elliott, Robert R. Shenk, Cheryl L. Thompson, and Hannah L. Gilmore, “Touch Preparations for the Intraoperative Evaluation of Sentinel Lymph Nodes After Neoadjuvant Therapy Have High False-Negative Rates in Patients With Breast Cancer,” Archives of Pathology & Laboratory Medicine, vol. 138, no. 6, pp. 814–818, 2014. View at Publisher · View at Google Scholar
  • Tjahjani Mirawati Soediro, and Frans Dhyanagiri Suyatna, “in vitro Modulation of P-glycoprotein, MRP-1 and BCRP Expression by Mangife rin in Doxorubicin-Treated MCF-7 Cells,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 4, pp. 1639–1642, 2014. View at Publisher · View at Google Scholar
  • Mariya Amin Quereshi, Beteena Kurian, and Leelamoni Kamalamma, “Screening for Breast Cancer in a Low Middle Income Country: Predictors in a Rural Area of Kerala, India,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 5, pp. 1919–1924, 2014. View at Publisher · View at Google Scholar
  • Ammad Ahmad Farooqi, Muhammad Zahid Qureshi, Ghazala Butt, and Aliye Aras, “Anthocyanins: Targeting of Signaling Networks in Cancer Cells,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 5, pp. 2379–2381, 2014. View at Publisher · View at Google Scholar
  • Nisrin Mohammad Anfinan, Basem Eldeek, Jawher Al-Ahmadi, Maha Al-Attas, Hesham Khalid Sait, Hussain Abdullah Basalamah, Nabeel Al-Ama, and Mohamed Eid El-Sayed, “Perception of Patients with Cancer towards Support Management Services and Use of Complementary Alternative Medicine - a Single Institution Hospital-B ased Study in Saudi Arabia,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 6, pp. 2547–2554, 2014. View at Publisher · View at Google Scholar
  • Amina Iqbal Khan, Neelam Siddiqui, Nargis Muzaffar, Aamir Ali Syed, Mazhar Ali Shah, and Arif Jamshed, “Outcomes of Triple-Negative Versus Non-Triple-Negative Breast Cancers Manag ed with Breast-Conserving Therapy,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 6, pp. 2577–2581, 2014. View at Publisher · View at Google Scholar
  • Sifeng Tao, Haifei He, Qiang Chen, and Wenjie Yue, “GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Ruichuan Chen, Jasper H. N. Yik, Qiao Jing Lew, and Sheng-Hao Chao, “Brd4 and HEXIM1: Multiple Roles in P-TEFb Regulation and Cancer,” BioMed Research International, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Lea A. Koch, Volker Schmitz, Christian P. Strassburg, and Esther Raskopf, “Plasmid Transfer of Plasminogen K1-5 Reduces Subcutaneous Hepatoma Growth by Affecting Inflammatory Factors,” BioMed Research International, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Hua Shen, Jinyuan Liu, Rong Wang, Xu Qian, Ruitong Xu, Tongpeng Xu, Qi Li, Lin Wang, Zhumei Shi, Jitai Zheng, and Qiudan Chen, “Fulvestrant increases gefitinib sensitivity in non-small cell lung cancer c ells by upregulating let-7c expression,” Biomedicine & Pharmacotherapy, vol. 68, no. 3, pp. 307–313, 2014. View at Publisher · View at Google Scholar
  • Yiyi Liu, Quanquan Gu, Jack P. Hou, and Jiawei Han, “A network-assisted co-clustering algorithm to discover cancer subtypes base d on gene expression,” Bmc Bioinformatics, vol. 15, 2014. View at Publisher · View at Google Scholar
  • Isabel Fonseca, Sergio Dias, and J. C. Mendes de Almeida, “Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breas t tumor progression,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Fakher Rahim, Saeideh Hajizamani, Esmaeil Mortaz, Ahmad Ahmadzadeh, Mohammad Shahjahani, Saeid Shahrabi, and Najmaldin Saki, “Molecular Regulation of Bone Marrow Metastasis in Prostate and Breast Cancer,” Bone Marrow Research, vol. 2014, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  • Heidi S. Wirtz, Denise M. Boudreau, Julie R. Gralow, William E. Barlow, Shelly Gray, Erin J. A. Bowles, and Diana S. M. Buist, “Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Candyce H. Kroenke, Carol Sweeney, Marilyn L. Kwan, Charles P. Quesenberry, Erin K. Weltzien, Laurel A. Habel, Adrienne Castillo, Phillip S. Bernard, Rachel E. Factor, Lawrence H. Kushi, and Bette J. Caan, “Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • C. Arce-Salinas, J. L. Aguilar-Ponce, C. Villarreal-Garza, F. U. Lara-Medina, D. Olvera-Caraza, A. Alvarado Miranda, D. Flores-Díaz, and A. Mohar, “Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Susann E. Schetter, Terryl J. Hartman, Jason Liao, John P. Richie, Bogdan Prokopczyk, Cindy DuBrock, Carina Signori, Christopher Hamilton, Laurence M. Demers, Karam El-Bayoumy, and Andrea Manni, “Differential impact of body mass index on absolute and percent breast density: implications regarding their use as breast cancer risk biomarkers,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • Cynthia Villarreal-Garza, Daniel Khalaf, Nathaniel Bouganim, Mark Clemons, Omar Peña-Curiel, Berenice Baez-Revueltas, Alexander Kiss, Farah Kassam, Katherine Enright, Sunil Verma, Kathleen Pritchard, Jeff Myers, and Rebecca Dent, “Platinum-based chemotherapy in triple-negative advanced breast cancer,” Breast Cancer Research and Treatment, 2014. View at Publisher · View at Google Scholar
  • H Karra, H Repo, I Ahonen, E Löyttyniemi, R Pitkänen, M Lintunen, T Kuopio, M Söderström, and P Kronqvist, “Cdc20 and securin overexpression predict short-term breast cancer survival,” British Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • D Sengupta, D K Bhargava, A Dixit, B S Sahoo, S Biswas, G Biswas, and S K Mishra, “ERRβ signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells,” British Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • Aneel Paulus, Kasyapa Chitta, Sharoon Akhtar, David Personett, Kena C. Miller, Kevin J. Thompson, Jennifer Carr, Shaji Kumar, Vivek Roy, Stephen M. Ansell, Joseph R. Mikhael, Angela Dispenzieri, Craig B. Reeder, Candido E. Rivera, and James Foran, “AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma a nd Waldenstrom macroglobulinaemia,” British Journal of Haematology, vol. 164, no. 3, pp. 352–365, 2014. View at Publisher · View at Google Scholar
  • Maria Gere, Miklos Tarjan, Dan Hellberg, and Tibor Tot, “Molecular Phenotype of the Foci in Multifocal Invasive Breast Carcinomas,” Cancer, vol. 120, no. 1, pp. 26–34, 2014. View at Publisher · View at Google Scholar
  • Rainer J. Klement, and Colin E. Champ, “Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R’s through dietary manipulation,” Cancer and Metastasis Reviews, 2014. View at Publisher · View at Google Scholar
  • Michael Scully, Gloria Petralia, and Ajay Kakkar, “Binding and inhibition of drug transport proteins by heparin A potential dr ug transporter modulator capable of reducing multidrug resistance in human cancer cells,” Cancer Biology & Therapy, vol. 15, no. 1, pp. 135–145, 2014. View at Publisher · View at Google Scholar
  • Witold Lasek, Radosław Zagożdżon, and Marek Jakobisiak, “Interleukin 12: still a promising candidate for tumor immunotherapy?,” Cancer Immunology, Immunotherapy, 2014. View at Publisher · View at Google Scholar
  • Zaima Mazorra Herrera, and Tania Crombet Ramos, “Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients,” Cancer Immunology, Immunotherapy, 2014. View at Publisher · View at Google Scholar
  • Y. Rebecca Chin, Taku Yoshida, Andriy Marusyk, Andrew H. Beck, and Kornelia Polyak, “Targeting Akt3 Signaling in Triple-Negative Breast Cancer,” Cancer Research, vol. 74, no. 3, pp. 964–973, 2014. View at Publisher · View at Google Scholar
  • Emilia Montagna, Giuseppe Cancello, Silvia Dellapasqua, Elisabetta Munzone, and Marco Colleoni, “Metronomic therapy and breast cancer: a systematic review,” Cancer Treatment Reviews, 2014. View at Publisher · View at Google Scholar
  • Hua Guo, Yuanyuan Liu, Yan Wang, Jing Wu, Xiaoying Yang, Rongshan Li, Yinsong Wang, and Ning Zhang, “pH-sensitive pullulan-based nanoparticle carrier for adriamycin to overcome drug-resistance of cancer cells,” Carbohydrate Polymers, 2014. View at Publisher · View at Google Scholar
  • Chun Wang, Can-Xin Xu, Yiwen Bu, and Kathleen M. Bottum, “Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast ca ncer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAP K/ERK signaling,” Carcinogenesis, vol. 35, no. 3, pp. 703–713, 2014. View at Publisher · View at Google Scholar
  • B. Humphries, Z. Wang, A. L. Oom, T. Fisher, D. Tan, Y. Cui, Y. Jiang, and C. Yang, “MicroRNA-200b targets protein kinase C  and suppresses triple-negative breast cancer metastasis,” Carcinogenesis, 2014. View at Publisher · View at Google Scholar
  • A Paul, S Gunewardena, S R Stecklein, B Saha, N Parelkar, M Danley, G Rajendran, P Home, S Ray, I Jokar, G A Vielhauer, R A Jensen, O Tawfik, and S Paul, “PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis,” Cell Death and Differentiation, 2014. View at Publisher · View at Google Scholar
  • Anna Paszel-Jaworska, Barbara Bednarczyk-Cwynar, Lucjusz Zaprutko, Mariusz Kaczmarek, and Maria Rybczynska, “Methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate (HIMOXOL), a synthetic olea nolic acid derivative, induces both apoptosis and autophagy in MDA-MB-231 b reast cancer cells,” Chemico-Biological Interactions, vol. 208, pp. 47–57, 2014. View at Publisher · View at Google Scholar
  • Suet M. Chan, Vivien Ng, Brendan M. Smith, Hilary Umeh, and Stephen P. Courtney, “Risk Stratification of Patients With Early Breast Cancer,” Clinical Breast Cancer, vol. 14, no. 1, pp. 68–73, 2014. View at Publisher · View at Google Scholar
  • Vivian Labovsky, Leandro Marcelo Martinez, Kevin Mauro Davies, Hernán García-Rivello, María de Luján Calcagno, Ayelén Matas, Valeria Beatriz Fernández-Vallone, Alejandra Wernicke, Hosoon Choi, and Norma Alejandra Chasseing, “Association between ligands and receptors related to the progression of early breast cancer in tumor epithelial and stromal cells,” Clinical Breast Cancer, 2014. View at Publisher · View at Google Scholar
  • Sharon Nofech-Moses, and Eileen Rakovitch, “Ductal Carcinoma In Situ of the Breast: Can Biomarkers Improve Current Mana gement?,” Clinical Chemistry, vol. 60, no. 1, pp. 60–67, 2014. View at Publisher · View at Google Scholar
  • Lisa L. Ferguson, Britne Curran, Mary Martinez, and Peggy Mancuso, “Triple-Negative Breast Cancer: What Is Known About It?,” Clinical Journal of Oncology Nursing, vol. 18, no. 1, pp. E6–E11, 2014. View at Publisher · View at Google Scholar
  • Lee Khuan, Halimatun Halaliah Mokhtar, Steven Eric Krauss, and Ong Beng Kok, “Hypertensive patients' preferences for complementary and alternative medicine and the influence of these preferences on the adherence to prescribed medication,” Complementary Therapies in Clinical Practice, 2014. View at Publisher · View at Google Scholar
  • Demetrios Simos, Mark Clemons, Ophira M. Ginsburg, and Carmel Jacobs, “Definition and consequences of locally advanced breast cancer,” Current Opinion in Supportive and Palliative Care, vol. 8, no. 1, pp. 33–38, 2014. View at Publisher · View at Google Scholar
  • Mark Clemons, Carmel Jacobs, and Demetrios Simos, “Treatment for locally advanced breast cancer,” Current Opinion in Supportive and Palliative Care, vol. 8, no. 1, pp. 30–32, 2014. View at Publisher · View at Google Scholar
  • Bing Zhang, Nedret Copur-Dahi, Denise Kalmaz, and Brigid S. Boland, “Gastrointestinal Manifestations of Breast Cancer Metastasis,” Digestive Diseases and Sciences, 2014. View at Publisher · View at Google Scholar
  • Carlos Eduardo Coral de Oliveira, Julie Massayo Maeda Oda, Roberta Losi Guembarovski, Karen Brajão de Oliveira, Carolina Batista Ariza, Jamil Soni Neto, Bruna Karina Banin Hirata, and Maria Angelica Ehara Watanabe, “CC Chemokine Receptor 5: The Interface of Host Immunity and Cancer,” Disease Markers, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Shannon Byler, and Sibaji Sarkar, “Do epigenetic drug treatments hold the key to killing cancer progenitor cells?,” Epigenomics, vol. 6, no. 2, pp. 161–165, 2014. View at Publisher · View at Google Scholar
  • John D. Groarke, Paul L. Nguyen, Anju Nohria, Roberto Ferrari, and Javid Moslehi, “The heart and other organs Cardiovascular complications of radiation therap y for thoracic malignancies: the role for non-invasive imaging for detectio n of cardiovascular disease,” European Heart Journal, vol. 35, no. 10, pp. 612–+, 2014. View at Publisher · View at Google Scholar
  • Tibor Tot, James Going, Maria Pia Foschini, Gyula Pekar, Lee Tucker, and Anna Sapino, “E04. Balancing between classic morphology and molecular medicine,” European Journal of Cancer, vol. 50, pp. S8–S9, 2014. View at Publisher · View at Google Scholar
  • A.D. Mwaka, E.S. Okello, and C.G. Orach, “Barriers to biomedical care and use of traditional medicines for treatment of cervical cancer: an exploratory qualitative study in northern Uganda,” European Journal of Cancer Care, 2014. View at Publisher · View at Google Scholar
  • Mohd S. Iqbal, Mohammad S. Hossain, and Louis W. Niessen, “Breast cancer in low-resource settings,” European Journal of Cancer Prevention, vol. 23, no. 4, pp. 286–287, 2014. View at Publisher · View at Google Scholar
  • Ahmed I. Foudah, Asmaa A. Sallam, and Mohamed R. Akl, “Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as b reast cancer migration and proliferation inhibitors,” European Journal of Medicinal Chemistry, vol. 73, pp. 310–324, 2014. View at Publisher · View at Google Scholar
  • Winnie K.W. So, Ka Ming Chow, Helen Y.L. Chan, Kai Chow Choi, Rayman W.M. Wan, Suzanne S.S. Mak, Sek Ying Chair, and Carmen W.H. Chan, “Quality of life and most prevalent unmet needs of Chinese breast cancer survivors at one year after cancer treatment,” European Journal of Oncology Nursing, 2014. View at Publisher · View at Google Scholar
  • Donna D'Alessio, Laura Liberman, Dilip Giri, Edi Brogi, and Elizabeth A. Morris, “Cancelled stereotactic biopsy of calcifications not seen using the stereota ctic technique: do we still need to biopsy?,” European Radiology, vol. 24, no. 4, pp. 907–912, 2014. View at Publisher · View at Google Scholar
  • Zheng Li, Hong Jiang, and Changmou Xu, “A Review: Using Nanoparticles to Enhance Absorption and Bioavailability of Phenolic Phytochemicals,” Food Hydrocolloids, 2014. View at Publisher · View at Google Scholar
  • Vladimir Riabov, Alexandru Gudima, Nan Wang, Amanda Mickley, Alexander Orekhov, and Julia Kzhyshkowska, “Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis,” Frontiers in Physiology, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Nadia Harbeck, Flavio Solca, and Thomas C Gauler, “Preclinical and clinical development of afatinib: a focus on breast cancer and squamous cell carcinoma of the head and neck,” Future Oncology, vol. 10, no. 1, pp. 21–40, 2014. View at Publisher · View at Google Scholar
  • Justin Stebbing, Victoria Harding, Catherine E Urch, Thomas Kaier, Guy Schofield, Matthew Flook, Constantine Alifrangis, Anna-Mary Young, Jacqueline A Shaw, R Charles Coombes, and Jonathan Krell, “The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancy,” Future Oncology, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Joshua G. Cohen, Arthur-Quan Tran, B.J. Rimel, Ilana Cass, Christine S. Walsh, Beth Y. Karlan, and Andrew J. Li, “Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival,” Gynecologic Oncology, 2014. View at Publisher · View at Google Scholar
  • Samantha Cohen, Rebecca Mosig, Erin Moshier, Elena Pereira, Jamal Rahaman, Monica Prasad-Hayes, Richard Halpert, Jean-Noel Billaud, Peter Dottino, and John A. Martignetti, “Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinoma,” Gynecologic Oncology, 2014. View at Publisher · View at Google Scholar
  • Angela de Maggio da Fonseca, Vicente Renato Bagnoli, Nestor de Barros, Erica Mendonca das Neves, Sandra Dircinha Teixeira de Araujo Moraes, Victor Hugo Souza Hortense, Jose Maria Soares, and Edmund Chada Baracat, “The expression of the estrogen receptor in obese patients with high breast density (HBD),” Gynecological Endocrinology, vol. 30, no. 1, pp. 78–80, 2014. View at Publisher · View at Google Scholar
  • A. Koch, and C. Mathelin, “An original oncoplastic reduction mammaplasty technique for breast cancers with high risk of incomplete excision,” Gynecologie Obstetrique & Fertilite, vol. 42, no. 3, pp. 160–167, 2014. View at Publisher · View at Google Scholar
  • Zaibo Li, Oluwole Fadare, Omar Hameed, and Chengquan Zhao, “Incidental atypical proliferative lesions in reduction mammoplasty specimen s in patients with a history of breast cancer,” Human Pathology, vol. 45, no. 1, pp. 104–109, 2014. View at Publisher · View at Google Scholar
  • Fathollah Tahmasebi, Tohid Kazemi, Mohammad Mehdi Amiri, Jalal Khoshnoodi, Jafar Mahmoudian, Ali Ahmad Bayat, Mahmood Jeddi-Tehrani, and Hodjatallah Rabbani, “In vitro assessment of the effects of anti-HER2 monoclonal antibodies on pr oliferation of HER2-overexpressing breast cancer cells,” Immunotherapy, vol. 6, no. 1, pp. 43–49, 2014. View at Publisher · View at Google Scholar
  • Michael Dinwiddie, Paul Terry, and Jiangang Chen, “Recent Evidence Regarding Triclosan and Cancer Risk,” International Journal of Environmental Research and Public Health, vol. 11, no. 2, pp. 2209–2217, 2014. View at Publisher · View at Google Scholar
  • K. M. Moore, G. J. Thomas, S. W. Duffy, J. Warwick, R. Gabe, P. Chou, I. O. Ellis, A. R. Green, S. Haider, K. Brouilette, A. Saha, S. Vallath, R. Bowen, C. Chelala, D. Eccles, W. J. Tapper, A. M. Thompson, P. Quinlan, L. Jordan, C. Gillett, A. Brentnall, S. Violette, P. H. Weinreb, J. Kendrew, S. T. Barry, I. R. Hart, J. L. Jones, and J. F. Marshall, “Therapeutic Targeting of Integrin  v 6 in Breast Cancer,” JNCI Journal of the National Cancer Institute, vol. 106, no. 8, pp. dju169–dju169, 2014. View at Publisher · View at Google Scholar
  • Jing Li, Chunquan Li, Junwei Han, Chunlong Zhang, Desi Shang, Qianlan Yao, Yunpeng Zhang, Yanjun Xu, Wei Liu, Meng Zhou, Haixiu Yang, Fei Su, and Xia Li, “The detection of risk pathways, regulated by miRNAs, via the integration of sample-matched miRNA-mRNA profiles and pathway structure,” Journal of Biomedical Informatics, 2014. View at Publisher · View at Google Scholar
  • Venkatesh Krishnan, Erwin A. Vogler, and Donna M. Sosnoski, “In Vitro Mimics of Bone Remodeling and the Vicious Cycle of Cancer in Bone,” Journal of Cellular Physiology, vol. 229, no. 4, pp. 453–462, 2014. View at Publisher · View at Google Scholar
  • Abbey J. Winant, and Syed A. Hoda, “Cystic apocrine hyperplasia is the most common finding in MRI detected brea st lesions,” Journal of Clinical Pathology, vol. 67, no. 2, pp. 182–186, 2014. View at Publisher · View at Google Scholar
  • V. Taleon, L. Dykes, W.L. Rooney, and L.W. Rooney, “Environmental effect on flavonoid concentrations and profiles of red and lemon-yellow sorghum grains,” Journal of Food Composition and Analysis, vol. 34, no. 2, pp. 178–185, 2014. View at Publisher · View at Google Scholar
  • Kosei Maemura, Shoji Natsugoe, and Sonshin Takao, “Molecular mechanism of cholangiocarcinoma carcinogenesis,” Journal of Hepato-Biliary-Pancreatic Sciences, 2014. View at Publisher · View at Google Scholar
  • Edgar C. Ontsouka, and Christiane Albrecht, “Cholesterol Transport and Regulation in the Mammary Gland,” Journal of Mammary Gland Biology and Neoplasia, 2014. View at Publisher · View at Google Scholar
  • Colin E. Champ, Joshua D. Palmer, Jeff S. Volek, Maria Werner-Wasik, David W. Andrews, James J. Evans, Jon Glass, Lyndon Kim, and Wenyin Shi, “Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme,” Journal of Neuro-Oncology, 2014. View at Publisher · View at Google Scholar
  • Yavuz Kececi, Funda Alkan Tasli, Ayse Yagcı, Emin Sır, Selin Canpolat, and Enver Vardar, “Histopathologic findings in breast reduction specimens,” Journal of Plastic Surgery and Hand Surgery, vol. 48, no. 2, pp. 122–125, 2014. View at Publisher · View at Google Scholar
  • Rachel N. Goble, Jennifer S. Drukteinis, M. Catherine Lee, Nazanin Khakpour, John V. Kiluk, and Christine Laronga, “Early experience with ultrasound features after intrabeam intraoperative radiation for early stage breast cancer,” Journal of Surgical Oncology, 2014. View at Publisher · View at Google Scholar
  • Youngjoo Kwon, “Curcumin as a cancer chemotherapy sensitizing agent,” Journal of the Korean Society for Applied Biological Chemistry, 2014. View at Publisher · View at Google Scholar
  • Hans Carl Hasselbalch, and Roskilde Hospital, “The Platelet-Cancer Loop in Myeloproliferative Cancer. Is Thrombocythemia an Enhancer of Cancer Invasiveness and Metastasis in Essential Thrombocythemia, Polycythemia Vera and Myelofibrosis?,” Leukemia Research, 2014. View at Publisher · View at Google Scholar
  • Shereef Elsamany, and Sakher Abdullah, “Triple-negative breast cancer: future prospects in diagnosis and management,” Medical Oncology, vol. 31, no. 2, 2014. View at Publisher · View at Google Scholar
  • Sagar Ghosh, Daniel Hughes, Dorothy Long Parma, Amelie Ramirez, and Rong Li, “Association of obesity and circulating adipose stromal cells among breast cancer survivors,” Molecular Biology Reports, 2014. View at Publisher · View at Google Scholar
  • Khaled Ghattass, Sally El-Sitt, Kazem Zibara, Saide Rayes, Makhluf J. Haddadin, and Hala Gali-Muhtasib, “The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway,” Molecular Cancer, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Padmanaban S. Suresh, Shao Ma, and Antimo Migliaccio, “Protein-Tyrosine Phosphatase H1 Increases Breast Cancer Sensitivity to Anti estrogens by Dephosphorylating Estrogen Receptor at Tyr537,” Molecular Cancer Therapeutics, vol. 13, no. 1, pp. 230–238, 2014. View at Publisher · View at Google Scholar
  • Damián E. Berardi, María I. Díaz Bessone, Andrea Motter, Elisa D. Bal de Kier Joffé, Alejandro J. Urtreger, and Laura B. Todaro, “Involvement of protein kinase C α and δ activities on the induction of the retinoic acid system in mammary cancer cells,” Molecular Carcinogenesis, 2014. View at Publisher · View at Google Scholar
  • Nicolas André, Manon Carré, and Eddy Pasquier, “Metronomics: towards personalized chemotherapy?,” Nature Reviews Clinical Oncology, 2014. View at Publisher · View at Google Scholar
  • Jenny E. Chu, Ying Xia, Benjamin Chin-Yee, David Goodale, and Alysha K. Croker, “Lung-Derived Factors Mediate Breast Cancer Cell Migration through CD44 Rece ptor-Ligand Interactions in a Novel Ex Vivo System for Analysis of Organ-Sp ecific Soluble Proteins,” Neoplasia, vol. 16, no. 2, pp. 180–+, 2014. View at Publisher · View at Google Scholar
  • Jeong-Hun Kang, “Protein Kinase C (PKC) Isozymes and Cancer,” New Journal of Science, vol. 2014, pp. 1–36, 2014. View at Publisher · View at Google Scholar
  • Carolina Pereira Zuconi, Ana Lígia Ceolin Alves, and Maria Isabel Toulson Davisson Correia, “Energy Expenditure in Women with Breast Cancer,” Nutrition, 2014. View at Publisher · View at Google Scholar
  • A R Daniel, A L Gaviglio, T P Knutson, J H Ostrander, A B D'Assoro, P Ravindranathan, Y Peng, G V Raj, D Yee, and C A Lange, “Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes,” Oncogene, 2014. View at Publisher · View at Google Scholar
  • Mridul Chowdhury, Wei Wu, M. D. Touhidul Imran Chowdhury, Bidhan Chandra Pal, Rifat Hasan, Zahid H. Khan, Dali Dutta, Arif Abu Saeem, Raiyan Al-Mansur, Sahin Mahmud, James H. Woods, Heather H. Story, and Reza Salim, “An mHealth Model to Increase Clinic Attendance for Breast Symptoms in Rural Bangladesh: Can Bridging the Digital Divide Help Close the Cancer Divide?,” Oncologist, vol. 19, no. 2, pp. 177–185, 2014. View at Publisher · View at Google Scholar
  • Yongshan Yao, Shenghan Chen, Xin Zhou, and Li Xie, “5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells,” Oncology Letters, vol. 7, no. 2, pp. 541–547, 2014. View at Publisher · View at Google Scholar
  • Cristina Raimondi, Angela Gradilone, Giuseppe Naso, and Nrico Cortesi, “Clinical utility of circulating tumor cell counting through CellSearch (R): the dilemma of a concept suspended in Limbo,” Oncotargets and Therapy, vol. 7, pp. 619–625, 2014. View at Publisher · View at Google Scholar
  • Milou S.C. Sep, Mara van Osch, Liesbeth M. van Vliet, Ellen M.A. Smets, and Jozien M. Bensing, “The power of clinicians’ affective communication: How reassurance about non-abandonment can reduce patients’ physiological arousal and increase information recall in bad news consultations. An experimental study using analogue patients,” Patient Education and Counseling, 2014. View at Publisher · View at Google Scholar
  • Laura Poillet, Nicolas Pernodet, Michael Boyer-Guittaut, Pascale Adami, Christophe Borg, Michele Jouvenot, and Regis Delage-Mourroux, “QSOX1 Inhibits Autophagic Flux in Breast Cancer Cells,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Bertrand De Meulder, Fabrice Berger, Eric Bareke, Sophie Depiereux, and Carine Michiels, “Meta-Analysis and Gene Set Analysis of Archived Microarrays Suggest Implica tion of the Spliceosome in Metastatic and Hypoxic Phenotypes,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Ming Shi, Yuanfei Yao, Fang Han, and Yiqun Li, “MAP1S Controls Breast Cancer Cell TLR5 Signaling Pathway and Promotes TLR5 Signaling-based Tumor Suppression,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Prathap Kumar S. Mahalingaiah, “Chronic Oxidative Stress Increases Growth and Tumorigenic Potential of MCF- 7 Breast Cancer Cells,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Ahmed A. Mostafa, Dianne Codner, Kensuke Hirasawa, Yumiko Komatsu, Matthew N. Young, and Viktor Steimle, “Activation of ER alpha Signaling Differentially Modulates IFN-gamma Induced HLA-Class II Expression in Breast Cancer Cells,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • James J. Cody, and James M. Markert, “Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Li Chen, Ze Zhang, Juhui Qiu, Lingling Zhang, and Jun Jang, “Chaperonin CCT-Mediated AIB1 Folding Promotes the Growth of ER alpha-Positi ve Breast Cancer Cells on Hard Substrates,” Plos One, vol. 9, no. 5, 2014. View at Publisher · View at Google Scholar
  • Abhita Malaviya, and Paul W. Sylvester, “Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells,” PPAR Research, vol. 2014, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Aneesh Pirlamarla, Adam Ferro, Ning J. Yue, Bruce G. Haffty, and Sharad Goyal, “Optimization of surgical clip placement for breast-conservation therapy,” Practical Radiation Oncology, vol. 4, no. 3, pp. 153–159, 2014. View at Publisher · View at Google Scholar
  • Yu Jin Lim, Kyubo Kim, Eui Kyu Chie, Wonshik Han, Dong Young Noh, and Sung W. Ha, “ Treatment outcome of ductal carcinoma in situ patients treated with postoperative radiation therapy ,” Radiation Oncology Journal, vol. 32, no. 1, pp. 1, 2014. View at Publisher · View at Google Scholar
  • Felipe A. Calvo, Morena Sallabanda, Claudio V. Sole, Carmen Gonzalez, Laura Alonso Murillo, Javier Martinez-Villanueva, Juan A. Santos, Javier Serrano, Ana Alavrez, Jose Blanco, Ana Calin, Marina Gomez-Espi, Miguel Lozano, and Rafael Herranz, “Intraoperative radiation therapy opportunities for clinical practice normalization: Data recording and innovative development,” Reports of Practical Oncology & Radiotherapy, vol. 19, no. 4, pp. 246–252, 2014. View at Publisher · View at Google Scholar